Clinical Trial Update: Fall Prevention by Alfacalcidol and Training [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating fall prevention with alfacalcidol and training has been withdrawn, involving older adults with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• One-Alpha (alfacalcidol)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Accidental Falls, Chronic Renal Insufficiency | Phase 4 | Status: WITHDRAWN